Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for the ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Alvogen Issues Voluntary Nationwide Recall of Clindamycin Injection Due to a Potential for a Lack of
Alvogen is voluntarily recalling seven lots of Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the ...
The Food and Drug Administration on Wednesday approved Baxter International’s clindamycin injection in saline. Clindamycin is a common antibiotic used to treat serious infections when penicillin may ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Abraxis BioScience Receives FDA Approvals for Clindamycin Injection, USP LOS ANGELES -- Abraxis BioScience, Inc., an integrated, global biopharmaceutical company, today announced that it has received ...
The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance. On June 16, 2017, Alvogen announced it was ...
Co announces it has received two approvals from the FDA for its Abbreviated New Drug Applications for Clindamycin Injection, 300mg, 600mg, 900mg and 9g, USP, the generic equivalent of Pfizer's Cleocin ...
Clindamycin (as phosphate) 150mg/mL; contains benzyl alcohol. Serious: 0.6–1.2g daily. More severe: 1.2–2.7g/day IM or IV. Both: give in 2–4 equally divided doses; max 600mg per IM inj and 4.8g/day IV ...
Alvogen is arranging with its distributors and customers for the return of the recalled lots of clindamycin. Hospira, a unit of Pfizer, voluntarily recalled four other injectable solutions made at its ...
* Baxter announces U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline * Baxter International - FDA approval and commercial launch of ready-to-use clindamycin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results